Derek C. Radisky received his B.Sc. in Chemistry and Ph.D. in Pathology from the University of Utah. He worked as a post-doctoral researcher at the Life Sciences Division, Lawrence Berkeley National Laboratory. He is a cancer biology researcher at the Mayo Clinic and investigates the inductive signals in the microenvironment that drive cancer development and disease progression. His research leverages a combination of physiologically relevant, engineered cell culture systems, physiologically relevant preclinical models, and evaluation of human tissue cohorts. Prof. Radisky also uses premalignant breast tissue derived from benign breast biopsies to identify novel pathways of breast cancer development that can be targeted with improved prevention and treatment strategies. His goals are to reduce cancer incidence, improve therapeutic outcomes, and decrease cancer disparities.